Irx Therapeutics

140 58th St Ste A
Brooklyn, NY 11220

Innovimmune is a privately-held biotechnology company based in New York, specializing in the development of novel oral small molecule immunomodulatory drugs aimed at treating cancer, autoimmune diseases, and chronic inflammation. The company is committed to advancing its innovative product pipeline through the application of cutting-edge techniques such as structure-guided drug design and artificial intelligence.

With a focus on delivering first-in-class and best-in-class therapeutics, Innovimmune collaborates with leading medical experts and academic institutions to ensure rigorous research and development. The company actively seeks strategic partnerships to expedite the clinical development and commercialization of its pioneering therapeutic discoveries.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkBrooklynIrx Therapeutics